2021
DOI: 10.1038/s41467-021-23903-5
|View full text |Cite
|
Sign up to set email alerts
|

Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disorders

Abstract: Lysosomal storage disorders characterized by altered metabolism of heparan sulfate, including Mucopolysaccharidosis (MPS) III and MPS-II, exhibit lysosomal dysfunctions leading to neurodegeneration and dementia in children. In lysosomal storage disorders, dementia is preceded by severe and therapy-resistant autistic-like symptoms of unknown cause. Using mouse and cellular models of MPS-IIIA, we discovered that autistic-like behaviours are due to increased proliferation of mesencephalic dopamine neurons origina… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
16
0
4

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 23 publications
(24 citation statements)
references
References 70 publications
(118 reference statements)
4
16
0
4
Order By: Relevance
“…As MPS IIIA HS GAG is freely diffusible the FGF2 bound to it may no longer be localized where it can bind to the FGFR. This finding is also supported by de Risi (2021) who showed using the same MTS assay in Baf32 cells that MPS IIIA HS extracts failed to induce proliferation mediated by FGF2 in comparison to wildtype HS [66] . Thus the abnormal turnover of HS in MPS IIIA and the accumulation of high levels of abnormally structured HS in the CNS clearly interrupts the delicate balance between FGF2 growth factor/growth factor receptor/growth factor co-receptor in NPC proliferation.…”
Section: Discussionsupporting
confidence: 72%
See 1 more Smart Citation
“…As MPS IIIA HS GAG is freely diffusible the FGF2 bound to it may no longer be localized where it can bind to the FGFR. This finding is also supported by de Risi (2021) who showed using the same MTS assay in Baf32 cells that MPS IIIA HS extracts failed to induce proliferation mediated by FGF2 in comparison to wildtype HS [66] . Thus the abnormal turnover of HS in MPS IIIA and the accumulation of high levels of abnormally structured HS in the CNS clearly interrupts the delicate balance between FGF2 growth factor/growth factor receptor/growth factor co-receptor in NPC proliferation.…”
Section: Discussionsupporting
confidence: 72%
“…A very recent study generated a SH-SY5Y neuroblastoma cell line based MPS IIIA model using CRISPR-Cas9 disruption of SGSH. These neural progenitor-like cells displayed increased proliferation which was reduced when wildtype heparan sulphate was introduced into the cell media [66] , suggesting a role for HS in proliferative ability and neurodifferention of SH-SY5Y cells. Further evidence from de Pasquale et al (2021) using a NAGLU silenced neuroblastoma model of MPS IIIB highlights a key role for HSPGs in neurite outgrowth using the specific growth factor NK1 which is proposed to bind with high affinity the extracellular accumulated HS [68] .…”
Section: Discussionmentioning
confidence: 99%
“…This hyperdopaminergic state in MPS IIIa mice appears to be caused by developmental changes in the DA system: increased proliferation of mDA progenitors results in an increased number of mDA neurons in the SNpc and the VTA in the adult brain. Moreover, the same study shows that autisticlike behaviors and increased DA cell number are also present in a mouse model for a different type of MPS (MPS-II) (Risi et al, 2021). While this study suggests that altered development of the mDA system may be one of the causes of autism-like behaviors, it has not been investigated whether the increase in VTA neurons in these animal models leads also to alterations in the mesoprefrontal DA system.…”
Section: Autism Spectrum Disordersmentioning
confidence: 85%
“…Fresh single-cell suspensions obtained by the Trypsin-based enzymatic solution as described above were centrifuged 5 × 100× g and plated as in De Risi et al, 2021 [78] in a Neurobasal medium (NBM, Gibco, Milan, Italy), supplemented with B27 (Invitrogen, Milan, Italy), 2 mM L-glutamine (Gibco), penicillin, and streptomycin 10U + 10µg/mL (Pen/Strep, Sigma) with the addition of bFGF (20 ng/mL, Sigma), FGF8 (10 ng/mL, Sigma), and SHH (50 ng/mL; R&D systems, Abingdon-on-Thames, UK) at a density of 4 × 10 4 cells/cm 2 on poly-D-lysine (PDL) coated multiwells (15 µg/mL PDL for 1 h at 37 • C; Sigma).…”
Section: Mesencephalic Primary Cultures (Me125-pcs)mentioning
confidence: 99%
“…iDA neurons were generated from Mouse embryonic fibroblasts (MEFs) as previously described [36,78,80]. In brief, MEFs isolated from E14.5 mice embryos were infected with lentiviral particles coding for the TFs Ascl1, Nurr1, and Lmx1a in DMEM (Gibco) supplemented with 10% FBS, Pen/Strep, and doxycycline (4 µg/mL).…”
Section: Mef and Ida Reprogrammingmentioning
confidence: 99%